Evidence map›Paper›PMID 37133524›Full record

ArticleEuropean biophysics journal : EBJ2023

Hydrodynamic characterization of a vesicular stomatitis virus-based oncolytic virus using analytical ultracentrifugation.

Simon Wawra, Sophia Kessler, Arina Egel, Johannes Solzin, Oliver Burkert, Daniel Hochdorfer

Abstract read
In one paragraph

Article in European biophysics journal : EBJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An automated interface for sedimentation velocity analysis in SEDFIT.bioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simon WawraBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Analytical Development Biologicals, Biberach, Germany. simon.wawra@boehringer-ingelheim.com.ORCID http://orcid.org/0000-0003-4859-8761
Sophia KesslerBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Viral Therapeutics Center, Biberach, Germany.
Arina EgelBoehringer Ingelheim Therapeutics GmbH, Innovation Unit, Viral Therapeutics Center, Ochsenhausen, Germany.
Johannes SolzinBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Viral Therapeutics Center, Biberach, Germany.
Oliver BurkertBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Analytical Development Biologicals, Biberach, Germany.
Daniel HochdorferBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Viral Therapeutics Center, Biberach, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determination of the size, density, and mass of viral particles can provide valuable information to support process and formulation studies in clinical development. Analytical ultracentrifugation (AUC), as a first principal method, has been shown to be a beneficial tool for the characterization of the non-enveloped adeno associated virus (AAV). Here, we demonstrate the suitability of AUC for the challenging characterization of a representative for enveloped viruses, which usually are expected to exhibit higher dispersity than non-enveloped viruses. Specifically, the vesicular stomatitis virus (VSV)-based oncolytic virus VSV-GP was used to evaluate potential occurrence of non-ideal sedimentation by testing different rotor speeds and loading concentrations. The partial specific volume was determined via density gradients and density contrast experiments. Additionally, nanoparticle tracking analysis (NTA) was used to determine the hydrodynamic diameter of VSV-GP particles to calculate their molecular weight via the Svedberg equation. Overall, this study demonstrates the applicability of AUC and NTA for the characterization of size, density, and molar mass of an enveloped virus, namely VSV-GP.

Indexed as

Oncolytic VirotherapyOncolytic VirusesVesicular StomatitisAnimalsHumansHydrodynamicsUltracentrifugationVesicular stomatitis Indiana virusVesiculovirusAnalytical ultracentrifugationNanoparticle tracking analysisOncolytic virusVesicular stomatitis virus

Identifiers

PMID37133524
PMCPMC10444643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.